SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-298696
Filing Date
2023-12-19
Accepted
2023-12-19 16:59:00
Documents
19
Period of Report
2023-12-18
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d47305d8k.htm   iXBRL 8-K 33317
2 EX-1.1 d47305dex11.htm EX-1.1 197036
3 EX-4.1 d47305dex41.htm EX-4.1 77362
4 EX-5.1 d47305dex51.htm EX-5.1 14411
5 EX-99.1 d47305dex991.htm EX-99.1 9736
9 GRAPHIC g47305g1218115653600.jpg GRAPHIC 1649
10 GRAPHIC g47305g1218120047751.jpg GRAPHIC 3679
11 GRAPHIC g47305g1218120434647.jpg GRAPHIC 6662
  Complete submission text file 0001193125-23-298696.txt   557373

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA syrs-20231218.xsd EX-101.SCH 2845
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE syrs-20231218_lab.xml EX-101.LAB 17236
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE syrs-20231218_pre.xml EX-101.PRE 10809
13 EXTRACTED XBRL INSTANCE DOCUMENT d47305d8k_htm.xml XML 3226
Mailing Address 35 CAMBRIDGE PARK DRIVE CAMBRIDGE MA 02140
Business Address 35 CAMBRIDGE PARK DRIVE CAMBRIDGE MA 02140 617-744-1340
Syros Pharmaceuticals, Inc. (Filer) CIK: 0001556263 (see all company filings)

IRS No.: 453772460 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37813 | Film No.: 231498211
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)